CTBO (Cantabio Pharmaceuticals) Interest Expense: $-1.21 Mil (TTM As of Dec. 2018)


What is Cantabio Pharmaceuticals Interest Expense?

Cantabio Pharmaceuticals CTBO Interest Expense is $-1.21 Mil as of Dec. 2018.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cantabio Pharmaceuticals's interest expense for the three months ended in Dec. 2018 was $ -0.35 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2018 was $-1.21 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cantabio Pharmaceuticals's Operating Income for the three months ended in Dec. 2018 was $ -0.24 Mil. Cantabio Pharmaceuticals's Interest Expense for the three months ended in Dec. 2018 was $ -0.35 Mil. Cantabio Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cantabio Pharmaceuticals  (OTCPK:CTBO) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cantabio Pharmaceuticals's Interest Expense for the three months ended in Dec. 2018 was $-0.35 Mil. Its Operating Income for the three months ended in Dec. 2018 was $-0.24 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2018 was $0.00 Mil.

Cantabio Pharmaceuticals's Interest Coverage for the quarter that ended in Dec. 2018 is calculated as

Cantabio Pharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Cantabio Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Interest Expense Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Interest Expense
Get a 7-Day Free Trial 0.00 0.00 0.00 -0.04 -0.62

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.21 -0.23 -0.35 -0.29 -0.35

Cantabio Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-1.21 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Interest Expense of $-1.21 Mil as of Dec. 2018. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Interest Expense too high?
Cantabio Pharmaceuticals' current Interest Expense is $-1.21 Mil.
How does Cantabio Pharmaceuticals' Interest Expense compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Interest Expense of $-1.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Interest Expense is $-1.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Interest Expense of $-1.21 Mil. The current Interest Expense is $-1.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Interest Expense is $-1.21 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.